Edition:
United States

Financial Services & Real Estate Headlines

Novartis CEO plays down prospects for Actelion bid - Blick

VIENNA, Dec 4 Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson & Johnson about a transaction.

Aixtron, Fujian to explore what is left of deal after U.S. veto

FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.

Actelion's silence has hedge funds betting big on J&J deal

ZURICH, Dec 2 Actelion's silence speaks volumes to the dozens of event-driven hedge funds piling into the Swiss biotech firm, betting that Johnson & Johnson's (J&J) approach will result in an outright takeover and handsome returns.

Buffett's Berkshire is urged to sell fossil fuel stocks

Dec 2 A Nebraska nonprofit on Friday said it will propose that Warren Buffett's Berkshire Hathaway Inc sell its investments in oil refiner Phillips 66 and other companies involved in fossil fuels over 12 years.

EU mergers and takeovers (Dec 2)

BRUSSELS, Dec 2 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Junk bond bankers pin hopes on M&A surge

NEW YORK, Dec 2 (IFR) - An uptick in M&A activity should help bolster US junk bond sales next year, reversing a three-year decline in primary volumes for the asset class - or so bankers hope.

« Previous Page Next Page »